Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6340-44-9

Post Buying Request

6340-44-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6340-44-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 6340-44-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,4 and 0 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 6340-44:
(6*6)+(5*3)+(4*4)+(3*0)+(2*4)+(1*4)=79
79 % 10 = 9
So 6340-44-9 is a valid CAS Registry Number.

6340-44-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methoxyethyl(trimethyl)azanium,chloride

1.2 Other means of identification

Product number -
Other names Choline methyl ether chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6340-44-9 SDS

6340-44-9Downstream Products

6340-44-9Relevant articles and documents

The application of novel hydrophobic ionic liquids to the extraction of uranium(vi) from nitric acid medium and a determination of the uranyl complexes formed

Bell, Thomas James,Ikeda, Yasuhisa

experimental part, p. 10125 - 10130 (2011/12/04)

Novel ammonium based hydrophobic ionic liquids (ILs) have been synthesised and characterised, and their use in the liquid-liquid extraction of uranium(vi) from an aqueous nitric acid solution using tri-n-butyl phosphate (TBP), studied. On varying the nitr

Thiomolybdate analogues and uses thereof

-

, (2008/06/13)

The current invention provides novel thiomolybdate derivatives, methods of making novel thiomolybdate derivatives, pharmaceutical compositions of novel thiomolybdate derivatives, methods of using novel thiomolybdate derivatives to treat diseases associated with aberrant vascularization and methods of using pharmaceutical compositions of thiomolybdate derivatives to treat diseases associated with aberrant vascularization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6340-44-9